RVMD β€” REVOLUTION MEDICINES INC

Ownership history in RENAISSANCE TECHNOLOGIES LLC  Β·  8 quarters on record

This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in REVOLUTION MEDICINES INC (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.02% (2025 Q3)
πŸ“Š Avg. % of fund
0.01%
πŸ“… First filed
2021 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
8

Position Intelligence

RENAISSANCE TECHNOLOGIES LLC Γ— RVMD AI Analytics

πŸ“‰ RENAISSANCE TECHNOLOGIES LLC underperformed the S&P 500 by –22.9% annually on this RVMD position. Timing score: 43% (3/7 decisions correct). Average cost basis: $34.51. Maximum drawdown during holding period: –57.0%.

πŸ“ˆ Position Alpha vs SPY
-22.9%
annualised excess return

❌ Significantly underperformed the S&P 500 by 22.9% ann.
7 quarters analyzed

⏱️ Timing Score
43%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
3 of 7 add/trim decisions correct

πŸ’° Entry Quality
$34.51
+35.3% vs current ($46.70)

Best entry: $19.72 (2022 Q3)  Β·  Worst: $46.70 (2025 Q3)

πŸ›‘οΈ Drawdown Resilience
–57.0%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
88%
buy-side decisions

7 adds Β· 1 trim. Bought during 3 of 3 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.02% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    RVMD price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 8 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 253,104 +9,600 +3.9% 0.02% $11.8M $46.70
2025 Q2 ADDED 243,504 +100,700 +70.5% 0.01% $9.0M $36.79
2025 Q1 ADDED 142,804 +99,504 +229.8% 0.01% $5.0M $35.36
2023 Q1 REDUCED 43,300 -25,600 -37.2% 0.00% $938K $21.66
2022 Q3 ADDED 68,900 +13,800 +25.0% 0.00% $1.4M $19.72
2021 Q4 ADDED 55,100 +32,200 +140.6% 0.00% $1.4M $25.17
2021 Q2 ADDED 22,900 +13,300 +138.5% 0.00% $727K $31.74
2021 Q1 INITIATED 9,600 β€” β€” 0.00% $440K $45.88

🏒 Other funds also holding RVMD

As of 2025 Q4 β€” sorted by position size

AIHC Capital Management Ltd 67.21% Park Avenue Institutional Advisers LLC 3Y 7Y 40.5% Paradigm Biocapital Advisors LP 3Y 13.51% Casdin Capital, LLC 3Y 7Y 12.75% DAFNA Capital Management LLC 3Y 7Y 11.18% Alphabet Inc. 3Y 10.33% Logos Global Management LP 3Y 9.63% Checkpoint Capital L.P. 9.21% MIC Capital Management UK LLP 3Y 9.18% BVF INC/IL 3Y 7Y 9.0%
← Back to RENAISSANCE TECHNOLOGIES LLC Holdings